Sophia Genetics SA (SOPH) — 6-K Filings

6-K Filings (15)

• 6-K Filing — May 8, 2026
• SOPHiA GENETICS SA Files Routine 6-K Report — Nov 4, 2025 Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on November 4, 2025, for the period ending September 30, 2025. This report is a routine filing for foreign private issuers a
• SOPHiA GENETICS SA Files 6-K with Financial Updates — Aug 5, 2025 Risk: low
  SOPHiA GENETICS SA filed a 6-K report for the period ending June 30, 2025. The filing includes financial data such as issued capital, share premium, treasury sh
• SOPHiA GENETICS SA Shareholders Approve 2024 Financials — Jun 18, 2025 Risk: low
  On June 18, 2025, SOPHiA GENETICS SA held its annual general meeting where shareholders approved the 2024 Management Report, Annual Financial Statements, and Co
• SOPHiA GENETICS Releases 2024 ESG Impact Summary — May 16, 2025 Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on May 16, 2025, to announce the publication of its 2024 Environmental, Social and Governance (ESG) Impact Summary. This sum
• SOPHiA GENETICS SA Sets Annual Shareholder Meeting for June 18 — May 8, 2025 Risk: low
  SOPHiA GENETICS SA announced its annual general meeting of shareholders will be held on June 18, 2025, at 8:00 a.m. EDT / 2:00 p.m. CEST in Rolle, Switzerland.
• SOPHiA GENETICS SA Files 6-K for Q1 2025 — May 6, 2025 Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on May 6, 2025, for the period ending March 31, 2025. This report is incorporated by reference into their existing F-3 regis
• SOPHiA GENETICS SA Files 6-K Report — Nov 5, 2024 Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on November 5, 2024, for the period ending September 30, 2024. This report is a submission under Rule 13a-16 or 15d-16 of th
• SOPHiA GENETICS SA Files 6-K with Mid-Year Financials — Aug 6, 2024 Risk: low
  SOPHiA GENETICS SA filed a 6-K report for the period ending June 30, 2024. The filing includes financial data for the first six months of 2024 and the second qu
• SOPHiA GENETICS SA Annual Meeting Approves 2023 Financials — Jun 25, 2024 Risk: low
  SOPHiA GENETICS SA held its annual general meeting on June 24, 2024. Shareholders approved the 2023 Management Report, Annual Financial Statements, and Consolid
• SOPHiA GENETICS SA Reports 2024 AGM Results — Jun 24, 2024 Risk: low
  SOPHiA GENETICS SA announced the results of its 2024 Annual General Meeting held on June 24, 2024. Key resolutions included the approval of the annual accounts,
• SOPHiA GENETICS Releases 2023 ESG Impact Summary — Jun 7, 2024 Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on June 7, 2024, to announce the publication of its Environmental, Social, and Governance (ESG) Impact Summary for the year
• SOPHiA GENETICS Schedules Annual Shareholder Meeting for June 24 — May 15, 2024 Risk: low
  SOPHiA GENETICS SA announced its annual general meeting of shareholders will be held on June 24, 2024, at 8:00 a.m. EDT / 2:00 p.m. CEST. The meeting will take
• SOPHiA GENETICS SA Files Form 6-K — May 7, 2024 Risk: low
  SOPHiA GENETICS SA filed a Form 6-K on May 7, 2024, reporting on its activities for the month of May 2024. The filing includes information incorporated by refer
• SOPHiA GENETICS Touts Growth, 315K+ Analyses at J.P. Morgan Conf. — Jan 10, 2024
  SOPHiA GENETICS (Nasdaq: SOPH) is highlighting its near-term growth strategy at the 42nd annual J.P. Morgan Healthcare Conference on January 11, 2024. The compa

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX